Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 1
1979 1
1981 2
1982 1
1986 1
1987 1
1988 5
1990 1
1991 2
1992 1
1993 6
1994 3
1995 3
1996 4
1997 4
1998 5
1999 6
2000 7
2001 6
2002 6
2003 6
2004 6
2005 6
2006 9
2007 9
2008 12
2009 11
2010 12
2011 12
2012 16
2013 14
2014 15
2015 29
2016 25
2017 31
2018 20
2019 21
2020 39
2021 32
2022 34
2023 20
2024 9

Search Results

397 results

Results by year

Filters applied: . Clear all
Page 1
Hemorrhoid embolization: A review of current evidences.
Talaie R, Torkian P, Moghadam AD, Tradi F, Vidal V, Sapoval M, Golzarian J. Talaie R, et al. Among authors: vidal v. Diagn Interv Imaging. 2022 Jan;103(1):3-11. doi: 10.1016/j.diii.2021.07.001. Epub 2021 Aug 27. Diagn Interv Imaging. 2022. PMID: 34456172 Free article. Review.
Fenofibrate treatment for severe hypertriglyceridemia in dogs.
Miceli DD, Vidal VP, Blatter MFC, Pignataro OP, Castillo VA. Miceli DD, et al. Among authors: vidal vp. Domest Anim Endocrinol. 2021 Jan;74:106578. doi: 10.1016/j.domaniend.2020.106578. Epub 2020 Oct 8. Domest Anim Endocrinol. 2021. PMID: 33137654
Hemorrhoid Embolization: Is it Time for Standardization?
Tradi F, Vidal V. Tradi F, et al. Among authors: vidal v. Cardiovasc Intervent Radiol. 2022 Sep;45(9):1362-1363. doi: 10.1007/s00270-022-03205-z. Epub 2022 Aug 1. Cardiovasc Intervent Radiol. 2022. PMID: 35915268 No abstract available.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: vidal v. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Emborrhoid: Rectal Artery Embolization for Hemorrhoid Disease.
Panneau J, Mege D, Biseglie MD, Duclos J, Habert P, Vidal V, Tradi F. Panneau J, et al. Among authors: vidal v. Semin Intervent Radiol. 2022 Jun 30;39(2):194-202. doi: 10.1055/s-0042-1745800. eCollection 2022 Apr. Semin Intervent Radiol. 2022. PMID: 35781988 Free PMC article. Review. No abstract available.
[Central venous access in interventional radiology].
Habert P, Hak JF, Di Bisceglie M, Bartoli A, Gaubert JY, Vidal V, Tradi F. Habert P, et al. Among authors: vidal v. Presse Med. 2019 Oct;48(10):1141-1145. doi: 10.1016/j.lpm.2019.10.013. Epub 2019 Oct 25. Presse Med. 2019. PMID: 31669005 Review. French.
Bringing Interventional Radiology to Mars!
Vidal V, Boyer L, Luciani A; SFR-CNES collaborative group. Vidal V, et al. Cardiovasc Intervent Radiol. 2023 Apr;46(4):425-427. doi: 10.1007/s00270-023-03392-3. Epub 2023 Mar 14. Cardiovasc Intervent Radiol. 2023. PMID: 36918421
Epistaxis: The role of arterial embolization.
Reyre A, Michel J, Santini L, Dessi P, Vidal V, Bartoli JM, Moulin G, Varoquaux A. Reyre A, et al. Among authors: vidal v. Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):757-73. doi: 10.1016/j.diii.2015.06.006. Epub 2015 Jul 17. Diagn Interv Imaging. 2015. PMID: 26194159 Free article. Review.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Duffaud F, Blay JY, Le Cesne A, Chevreau C, Boudou-Rouquette P, Kalbacher E, Penel N, Perrin C, Laurence V, Bompas E, Saada-Bouzid E, Delcambre C, Bertucci F, Cancel M, Schiffler C, Monard L, Bouvier C, Vidal V, Gaspar N, Chabaud S. Duffaud F, et al. Among authors: vidal v. Br J Cancer. 2023 Dec;129(12):1940-1948. doi: 10.1038/s41416-023-02413-9. Epub 2023 Nov 1. Br J Cancer. 2023. PMID: 37914801 Clinical Trial.
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.
Sapoval M, Thiounn N, Descazeaud A, Déan C, Ruffion A, Pagnoux G, Duarte RC, Robert G, Petitpierre F, Karsenty G, Vidal V, Murez T, Vernhet-Kovacsik H, de la Taille A, Kobeiter H, Mathieu R, Heautot JF, Droupy S, Frandon J, Barry Delongchamps N, Korb-Savoldelli V, Durand-Zaleski I, Pereira H, Chatellier G; PARTEM study group. Sapoval M, et al. Among authors: vidal v. Lancet Reg Health Eur. 2023 Jun 26;31:100672. doi: 10.1016/j.lanepe.2023.100672. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37415648 Free PMC article.
397 results